Alternate Product Submission and Validation

The contract requires the development and validation of alternate stain products to meet stringent technical and regulatory standards for approval under a prime contract. The work involves creating new formulations that can serve as viable replacements for existing products, with complete documentation covering all aspects of composition, manufacturing processes, performance testing, and compliance with applicable regulations. This effort is critical to ensuring continuity and reliability in medical supply chains, particularly for surgical and diagnostic applications where product consistency and safety are paramount. The solicitation is issued under NAICS code 541690 for other scientific and technical consulting services, indicating a focus on specialized development rather than mass production. The place of performance is designated as Williamsburg, Virginia, with a response deadline of May 5, 2026, and the contract was posted on April 29, 2026. The contracting entity is the Medical Supply Chain MD Surg FSF under the Department of Defense, highlighting the military and healthcare significance of the products being developed. Subcontractors must be prepared to deliver not only functional products but also comprehensive, audit-ready technical and regulatory packages approved for prime contract integration.